Clinical Trial

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Study acronym: AERO-RMS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.
Trial Details
NCT Number NCT06924463
Lead Sponsor Lille University
Collaborators: Centre Oscar Lambret, Lille, France
Conditions Rhabdomyosarcoma
Enrollment 20 participants
Start Date 2025-03-13
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-04-11